FDA Approved Products

Application #	Type	Sponsor	Notes	Product #	Drug Name	Form	Strength	Active Ingredient	Approval Date	Marketing Status	Reference Standard
208912	NDA	EYEPOINT PHARMS		001	DEXYCU KIT	SUSPENSION;INTRAOCULAR	9%	DEXAMETHASONE	2018-02-09	Prescription	Yes